Bleeding Symptoms in Pediatric Patients with Congenital FVII Deficiency and Correlation to Thrombin Generation Assay Parameters: A Single-Center Retrospective Analysis

被引:0
作者
Di Felice, Giovina [1 ]
Iavarone, Sonia [2 ]
Montemari, Anna Lisa [1 ]
Tripiciano, Costanza [3 ]
Massoud, Michela [2 ]
Pezzi, Simona [1 ]
Giorni, Chiara [4 ]
Porzio, Ottavia [1 ,5 ]
Luciani, Matteo [2 ]
机构
[1] IRCCS, Bambino Gesu Childrens Hosp, Clin Lab Unit, I-00165 Rome, Italy
[2] IRCCS, Bambino Gesu Childrens Hosp, Oncohematol Cell & Gene Therapy & Bone Marrow Tran, I-00165 Rome, Italy
[3] IRCCS, Bambino Gesu Childrens Hosp, Infect Dis Unit, I-00165 Rome, Italy
[4] IRCCS, Bambino Gesu Childrens Hosp, Dept Cardiol & Cardiac Surg, Pediat Cardiac Intens Care Unit, I-00165 Rome, Italy
[5] Univ Roma Tor Vergata, Dept Expt Med, I-00133 Rome, Italy
来源
LIFE-BASEL | 2024年 / 14卷 / 12期
关键词
Factor VII; children; bleeding; thrombin generation; FACTOR-VII DEFICIENCY; CLINICAL PHENOTYPE; PROPHYLAXIS; MANAGEMENT; DIAGNOSIS; SEVERITY;
D O I
10.3390/life14121559
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Inherited factor VII deficiency is the most common rare bleeding disorder, affecting about 1/500,000 individuals without gender predilection. Most of the patients with FVII 20-50% are asymptomatic, but post-traumatic or post-surgical bleeding may often occur since there is not an exact correlation between FVII plasma levels and the bleeding phenotype. We enrolled 19 children and adolescents with FVII levels of 20-35% and 33 controls. Laboratory data collected included thrombin generation, prothrombin time, activated partial thromboplastin time, fibrinogen, and FVII levels. In our study, we found a statistical difference in the lag time ratio (p < 0.01) and tt-peak ratio (p < 0.05) between patients and controls but no difference in the other parameters, such as the endogenous thrombin potential (ETP). However, when we categorized patients, regardless of their bleeding scores, as presenting symptoms and having no symptoms, both the lag time ratio (p = 0.01) and tt-peak ratio (p < 0.05) were significantly different, and the vel. index % showed increased levels in patients without symptoms (p < 0.05). This study shows that thrombin generation may be a useful tool in assessing the risk of bleeding symptoms in children with an FVII deficiency categorized in the mild category (20-35%), although we cannot predict the severity of the bleeding.
引用
收藏
页数:12
相关论文
共 29 条
  • [1] Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis
    Bernardi, Francesco
    Mariani, Guglielmo
    [J]. HAEMATOLOGICA, 2021, 106 (02) : 351 - 362
  • [2] Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency
    Di Minno, Matteo Nicola Dario
    Dolce, Alberto
    Mariani, Guglielmo
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 109 (06) : 1051 - 1059
  • [3] Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project
    Elbatarny, M.
    Mollah, S.
    Grabell, J.
    Bae, S.
    Deforest, M.
    Tuttle, A.
    Hopman, W.
    Clark, D. S.
    Mauer, A. C.
    Bowman, M.
    Riddel, J.
    Christopherson, P. A.
    Montgomery, R. R.
    Rand, M. L.
    Coller, B.
    James, P. D.
    [J]. HAEMOPHILIA, 2014, 20 (06) : 831 - 835
  • [4] Use of global assays to understand clinical phenotype in congenital factor VII deficiency
    Greene, L. A.
    Goldenberg, N. A.
    Simpson, M. L.
    Villalobos-Menuey, E.
    Bombardier, C.
    Acharya, S. S.
    Santiago-Borrero, P. J.
    Cambara, A.
    DiMichele, D. M.
    [J]. HAEMOPHILIA, 2013, 19 (05) : 765 - 772
  • [5] Genotype-Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study
    Halimeh, Susan
    Koch, Lydia
    Kenet, Gili
    Kuta, Piotr
    Rahmfeld, Tess
    Stoll, Monika
    Nowak-Goettl, Ulrike
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [6] A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience
    Iwaniec, Teresa
    Zdziarska, Joanna
    Musial, Jacek
    Sanak, Marek
    [J]. HAMOSTASEOLOGIE, 2019, 39 (04): : 368 - 376
  • [7] Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic
    Jain, Shilpa
    Donkin, Jennifer
    Frey, Mary-Jane
    Peltier, Skye
    Gunawardena, Sriya
    Cooper, David L.
    [J]. JOURNAL OF BLOOD MEDICINE, 2018, 9 : 211 - 218
  • [8] Kim Shin-Hee, 2012, Korean J Hematol, V47, P281, DOI 10.5045/kjh.2012.47.4.281
  • [9] Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
    Konkle, B. A.
    Ebbesen, L. S.
    Erhardtsen, E.
    Bianco, R. P.
    Lissitchkov, T.
    Rusen, L.
    Serban, M. A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (09) : 1904 - 1913
  • [10] Primary prophylaxis for children with severe congenital factor VII deficiency - Clinical and laboratory assessment
    Kuperman, A. A.
    Barg, A. A.
    Fruchtman, Y.
    Shaoul, E.
    Rosenberg, N.
    Kenet, G.
    Livnat, T.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2017, 67 : 86 - 90